Search Results - "SCHECHTMAN, Joy"

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study by Broadwell, Aaron, Schechtman, Joy, Conaway, Douglas, Kivitz, Alan, Shiff, Natalie J, Black, Shawn, Xu, Stephen, Langholff, Wayne, Schwartzman, Sergio, Curtis, Jeffrey R

“…Biologic therapies are often prescribed for patients with rheumatoid arthritis (RA) who have inadequate responses to or are intolerant of methotrexate (MTX)…”
Get full text

Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis by TESSER, John, FLEISCHMANN, Roy, DORE, Robin, BENNETT, Ralph, SOLINGER, Alan, JOH, Tenshang, MODAFFERI, Dennis, SCHECHTMAN, Joy

“…OBJECTIVE: To examine the safety of anakinra when added to a background of standard rheumatoid arthritis (RA) medications in patients with RA with active…”
Get full text

Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis by Clark, Michael, Zhou, Yiying, Sweet, Kristen, Asnal, Cecilia Adma, Berman, Alberto, Citera, Gustavo, Rodriguez, Graciela, Savio, Veronica Gabriela, Bird, Paul, Griffiths, Hedley, Nicholls, David, Rischmueller, Maureen, Zochling, Jane, Malaise, Michel, Vanhoof, Johan, Bonfiglioli, Rubens, Scotton, Antonio Scafuto, Ximenes, Antonio Carlos, Atanasov, Assen, Goranov, Ivan, Kazmin, Ivan, Stoilov, Rumen, Bessette, Louis, Rodrigues, Jude, Bortilik, Ladislav, Dokoupilova, Eva, Dvoarak, Zdenek, Podrazilova, Lucie, Simkova, Gabriela, Stejfova, Zuzana, Moravcova, Radka, Baillet, Athan, Banneville, Beatrice, Nguyen, Minh, Braun, Juergen, Everding, Andrea, Drescher, Edit, Kerekes, Kata, Pulai, Judit, Szanto, Sandor, Toth, Edit, Avila, Hilario, Torre, Igancio Garcia, Irazoque, Fedra, Maradiaga, Marco, Pacheco, Cesar, Brzosko, Marek, Dudek, Anna, Jeka, Slawomir, Krogulec, Marek, Wiland, Piotr, Zielinska, Agnieszka, Santos, Helena, Bugrova, Olga, Christyakov, Valery, Ilivanova, Elena, Kamalova, Rima, Kameneva, Tatyana, Marusenko, Irina, Myasoedova, Svetlana, Myasoutova, Leisan, Plaksina, Tatyana, Polyakova, Svetlana, Savina, Liudmila, Smakotina, Svetlana, Ukhanova, Olga, Vinogradova, Irina, Zonova, Elena, Baek, Han Joo, Lee, Sang‐Hoon, Lee, Shin‐Seok, Song, YeongWook, Suh, Chang‐Hee, Ramos, Juan Amarelo, Diaz, Miguel Consuelo, Vivar, Maria Luz Garcia, Chen, Hsiang‐Cheng, Chen, Kun‐Hung, Luo, Shue‐Fen, Tsai, Shih‐Tzu, Wei, Cheng‐Chung, Reshotko, Dmytro, Golovchenko, Oleksandr, Iaremenko, Oleg, Rekalov, Dmytro, Smiyan, Svitlana, Turianytsia, Samvel, Vasylets, Viktoriya, Virstyuk, Nataliya, Gaffney, Karl, Sengupta, Raj, Tahir, Hasan, Aelion, Jacob, Bennett, Ralph, Deodhar, Atul, Gonzalez‐Paoli, Julio, Griffin, Robert M., Grisanti, Michael, Peters, Eric, Schechtman, Joy

“…Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐controlled studies in patients with axial spondyloarthritis (SpA)…”
Get full text

Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial by KIVITZ, Alan J, SCHECHTMAN, Joy, TEXTER, Michele, FICHTNER, Andreas, DE LONGUEVILLE, Marc, CHARTASH, Elliot K

“…To evaluate the humoral immune response to pneumococcal and influenza vaccination in adults with rheumatoid arthritis (RA) receiving certolizumab pegol (CZP)…”
Get full text

P-146 Assessment of Immune Responses to Pneumococcal and Influenza Vaccines in Patients Receiving Certolizumab Pegol: ERRATUM by Kivitz, Alan, Schechtman, Joy, Texter, Michele, Fichtner, Andreas, Chartash, Elliot

Get full text

P-146 Assessment of Immune Responses to Pneumococcal and Influenza Vaccines in Patients Receiving Certolizumab Pegol by Kivitz, Alan, Schechtman, Joy, Texter, Michele, Fichtner, Andreas, Chartash, Elliot

Get full text

Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study by MEASE, Philip J, WEI, Nathan, GRAHAM, Galen E, WIESENHUTTER, Craig W, WILLIS, Larry, RUDERMAN, Eric M, FORSTOT, Joseph Z, MARICIC, Michael J, DAO, Kathryn H, PRITCHARD, Charles H, FISKE, Darrell N, BURCH, Francis X, FUDMAN, Edward J, PRUPAS, H. Malin, ANKLESARIA, Pervin, HEALD, Alison E, KIVITZ, Alan J, SCHECHTMAN, Joy, TRAPP, Robert G, HOBBS, Kathryn F, GREENWALD, Maria, HOU, Antony, BOOKBINDER, Stephen A

“…To assess safety and clinical outcomes in patients with inflammatory arthritis after intraarticular (IA) injection of rAAV2-TNFR:Fc, a recombinant…”
Get full text

The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis by DORE, R. K, MATHEWS, S, SCHECHTMAN, J, SURBECK, W, MANDEL, D, PATEL, A, ZHOU, L, PELOSO, P

“…To evaluate the immunogenicity, safety, and efficacy of 50 mg/mL liquid etanercept. In a multicenter, open-label study, adults with active rheumatoid arthritis…”
Get full text

A Pulsed Electrical Joint Stimulator for the Treatment of Osteoarthritis of the Hand and Wrist by Holt, Peter A, Ozyurekoglu, Tuna, Deveshwar, Shaili, Maclaughlin, Edmund J, Khlopas, Anton, Mont, Michael A, Pang, Shirley W, Tuber, Jack S, Schechtman, Joy, Zizic, Thomas M

“…The hand is commonly affected by osteoarthritis (OA). The development and progression of OA are believed to involve inflammation, even in the early stages of…”
Get full text

Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: A randomized, controlled trial by LISSE, Jeffrey R, PERLMAN, Monica, JOHANSSON, Gunnar, SHOEMAKER, James R, SCHECHTMAN, Joy, SKALKY, Carol S, DIXON, Mary E, POLIS, Adam B, MOLLEN, Arthur J, GEBA, Gregory P

“…Gastrointestinal (GI) toxicity mediated by dual cyclooxygenase (COX)-1 and COX-2 inhibition of nonsteroidal anti-inflammatory drugs (NSAIDs) can cause serious…”
Get full text

Synergistic effect of using a transcutaneous electrical joint stimulator and an unloading brace in treating osteoarthritis of the knee by Hungerford, David S, Maclaughlin, Edmund J, Mines, Craig M, Deveshwar, Shaili, Elliott, Cynthia, Tuber, Jack S, Principe, John R, Ford, Theresa Lawrence, Schechtman, Joy, Zizic, Thomas M

“…Medical treatments and less invasive surgical approaches for knee osteoarthritis are variably effective, and total knee arthroplasty (TKA) is generally…”
Get full text

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial by Emery, Paul, Fleischmann, Roy, Filipowicz‐Sosnowska, Anna, Schechtman, Joy, Szczepanski, Leszek, Kavanaugh, Arthur, Racewicz, Artur J., van Vollenhoven, Ronald F., Li, Nicole F., Agarwal, Sunil, Hessey, Eva W., Shaw, Timothy M.

“…Objective To examine the efficacy and safety of different rituximab doses plus methotrexate (MTX), with or without glucocorticoids, in patients with active…”
Get full text

Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo‐controlled, dose‐ranging study by Genovese, Mark C., Kaine, Jeffrey L., Lowenstein, Mitchell B., Giudice, José Del, Baldassare, Andrew, Schechtman, Joy, Fudman, Edward, Kohen, Michael, Gujrathi, Sheila, Trapp, Robert G., Sweiss, Nadera J., Spaniolo, Greg, Dummer, Wolfgang

“…Objective Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, was studied in a first‐in‐human trial in rheumatoid arthritis (RA) patients receiving…”
Get full text

Anakinra, a recombinant human interleukin‐1 receptor antagonist (r‐metHuIL‐1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo‐controlled trial by Fleischmann, Roy M., Schechtman, Joy, Bennett, Ralph, Handel, Malcolm L., Burmester, Gerd‐Rudiger, Tesser, John, Modafferi, Dennis, Poulakos, Jennifer, Sun, Gordon

“…Objective To evaluate the safety of anakinra (a recombinant human interleukin‐1 receptor antagonist) in a large population of patients with rheumatoid…”
Get full text

The safety of anakinra in high‐risk patients with active rheumatoid arthritis: Six‐month observations of patients with comorbid conditions by Schiff, Michael H., DiVittorio, Gino, Tesser, John, Fleischmann, Roy, Schechtman, Joy, Hartman, Sanford, Liu, Thomas, Solinger, Alan M.

“…Objective To determine in a placebo‐controlled, double‐blind trial the safety profile of daily anakinra (Kineret) use in patients with active rheumatoid…”
Get full text